Hematology: Page 2

Blood tests show promise for TBI patient prognosis
By Leo O'Connor
The study, funded by the National Institutes of Health (NIH), found that biomarkers present in the blood on the day of a TBI can accurately predict a patient's risk of death or severe disability six months later.
August 10, 2022
2020 06 23 22 33 5774 3 D Medical Imaging
Quotient Q1 2023 revenues drop on customer order change
By LabPulse.com staff writers
For the quarter ended June 30, the Eysins, Switzerland-based firm posted a net loss of $38.9 million, or $.37 per share, compared to $27.3 million, or $.27 per share, in fiscal Q1 2022.
August 8, 2022
2020 06 18 17 24 6922 Immunoassay Analysis 400
Video from AACC: Beckman Coulter partners with Scopio
By Leo O'Connor
Dr. Peter Soltani, senior vice president and general manager at Beckman Coulter, and Itai Hayut, cofounder and CEO of Scopio Labs, spoke to LabPulse.com and ScienceBoard.net about the partnership.
July 31, 2022
2022 08 01 17 21 6187 Scopio And Bc 400
Smartphone app, blood test may predict clotting risk
By LabPulse.com staff writers
The test uses a smartphone's built-in vibration motor and camera to track movement of a copper particle in a drop of blood.
July 25, 2022
2022 07 26 15 43 0245 Blood Clot 400
Beckman, Scopio to partner on blood smear platforms
By LabPulse.com staff writers
Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.
July 19, 2022
2020 03 25 23 27 0591 Hands Shaking Deal 400
Philips adopting proteomics results for patient management
By LabPulse.com staff writers
The integration of proteomics results from the blood-based test -- along with the radiologic and patient history data currently used to determine treatment decisions -- can help create diagnostic efficiency for cancer care centers, Philips said.
June 29, 2022
2019 12 05 23 56 4761 Philips Rsna 2018 400
Quotient discloses underwritten public offering price
By LabPulse.com staff writers
The company said the aggregate net proceeds to Quotient from this offering are expected to be approximately $18.5 million. The company also offered all of the securities sold. Furthermore, Quotient granted the underwriters a 30-day option to purchase up to an additional 10,000,000 of its ordinary shares. The company said that it plans to use net proceeds to fund the ongoing development and commercialization of its MosaiQ microarray menu. It added that funds will go toward working capital, operating expenses, and other general corporate purposes.
June 23, 2022
2019 04 26 21 48 5250 Money Hundred Bills 400
Blood grouping, typing market estimated at $945 million
By Leo O'Connor
The overall market is expected to stabilize in 2022 and grow at a 1% compound annual growth rate (CAGR) through 2026 when revenues could reach $1 billion, according to the report, which is published by Kalorama Information, a sister publication of LabPulse.com.
June 16, 2022
2022 06 09 18 00 5852 Lab Blood Samples 400
PerkinElmer, Novartis expand newborn screening for SCD
By LabPulse.com staff writers
In collaboration with the Novartis Africa Sickle Cell Disease program, PerkinElmer aims to expand advocacy efforts to educate patients, caregivers, and communities about the importance of newborn screening and early intervention with hydroxyurea and other SCD treatments.
June 15, 2022
2022 06 16 16 53 9477 Sickle Cell Anemia2 400
FDA clears Scopio Labs hematology analysis platform
By LabPulse.com staff writers
Tel Aviv, Israel-based Scopio said the X100HT is a full-field digital imaging and artificial intelligence (AI)-enabled platform that combines high throughput with high resolution for hematological analysis.
June 9, 2022
2019 05 21 23 51 7032 Blood Cell Clot 400
SeekIn receives CE Mark for karyotyping kit
By LabPulse.com staff writers
Designed to show copy number alteration patterns in leukemia patients based on shallow whole-genome sequencing, the test can help hematologists make diagnoses and prognostic decisions based on European Leukemia Net, Revised International Prognostic Scoring System, or Revised International Staging System guidelines, according to the vendor.
April 6, 2022
2019 05 21 23 51 7032 Blood Cell Clot 400
PixCell signs MakGroup as distributor for the UAE
Dubai-based MakGroup will have exclusive distribution rights in the UAE for HemoScreen, a five-part, differential complete blood count analyzer that can provide results in five minutes, according to PixCell.
April 6, 2022
2020 09 08 18 51 2374 Business Handshake Meeting 400
Previous Page
Page 2 of 7
Next Page